SI
VIRX

Sofinnova Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Sofinnova Investments’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32,398
Closed -$816K – 69
2019
Q3 		$816K Buy
+32,398
New +$816K 0.07% 64